Research design and methods
This study was performed as part of a larger cross-sectional observational study (7) , to which microbleed-imaging and capillary microscopy were added at a later stage. In brief, 33 consecutive patients with proliferative retinopathy (PDR+), 34 patients without retinopathy (PDR-), 33 healthy controls underwent these novel measurements. Proliferative or no retinopathy was ascertained by fundus photography (ACM); microalbuminuria (albumin:creatinine ratio (ACR) >2.5 for men and >3.5mg/mol for women) by 24-hour urine sampling and neuropathy based on results of annual neuropathy check-up patients received or self-reported in case results were not available. PDR-patients had to be free of clinically manifest microangiopathy, whereas PDR+ patients could have other complications. The study was approved by the local Ethics Review Board and written informed consent was obtained of all participants.
Magnetic resonance imaging was performed on a 1.5T MR-system (Siemens-Sonata, Erlangen, Germany), using an 8-channel phased-array head coil. Cerebral microbleeds were assessed using T2* susceptibility weighted imaging (repetition time 48.0ms; echo time 40.0ms; flip angle 150; slice thickness 2.0mm (11) ), and white matter hyperintensities and lacunes using T2-FLAIR (repetition time 6500ms; echo time 385ms; variable flip angle (12) ; slice thickness 1.3 mm). All images were rated by a trained neuroradiologist (MPW). Cerebral small vessel disease markers were rated as absent or present and number of cerebral microbleeds was determined.
Peripheral microvascular function was assessed by capillary microscopy as described previously (13) . Nailfold capillaries in the dorsal skin of the third finger were visualized by a capillary microscope. Baseline capillary density was defined as the number of continuously erythrocyte-perfused capillaries per square millimeter (n/mm²). Capillary density during peak reactive hyperemia was counted after 4 minutes of arterial occlusion. Capillary recruitment was calculated as the relative increase in capillary density from baseline to capillary density during peak reactive hyperemia. Only Caucasians were included since skin capillary microscopy cannot be performed on a pigmented skin.
With 100 participants, a=0.05, power (1 2 b)=0.80, an effect size d=0.51 could be detected. Differences in subject characteristics were analyzed using one-way ANOVA or x 2 test. Participants were dichotomized on the presence or absence of small vessel disease. Logistic regression was performed to determine differences in prevalence of these markers, corrected for age, sex, and hypertension.
Multivariate ANCOVA, corrected for age, sex, and hypertension, was used to determine differences in skin capillary density between thosewith andwithout markers of small vessels disease. P , 0.05 was considered statistically significant. All analyses were performed using IMB-SPSS-20.0 (IBM-SPSS, Chicago, IL).
Results
Participant characteristics are shown in Table 1 . PDR+ patients were significantly older and had higher systolic blood pressure than the other two groups. A1C was significantly higher in both diabetes groups compared with healthy controls. PDR+ versus PDR-patients had longer disease duration, earlier onset age and higher hypertension rates (all p<0.05). There were no statistically significant differences between in-and excluded participants (Supplementary Table 1 ).
In 11 participants cerebral microbleeds were detected. Six had 1, 4 had 2 and 1 participant had 8 microbleeds. Cerebral microbleeds were more prevalent in PDR+ (n=7; 21%) compared with PDR-patients (n=1; 3%; p=0.01) and controls (n=3; 9%; p=0.02). Cerebral microbleeds prevalence did not differ between PDR-and controls (p=0.49). The difference between patient groups remained significant after adjustment for A1C, diabetes duration and ACR (p=0.05). Due to the low absolute number of cerebral microbleeds in these participants, further statistical testing was not performed. There was no statistically significant difference in white matter hyperintensities prevalence between PDR+ patients (n=8, 24,2%), PDR-patients (n=5; 14.7%) and controls (n=5; 15.2%; all p>0.05). Lacunes were not found in this cohort.
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Capillary microscopy data are shown in Supplementary Figure 1 . There was a trend across groups towards lower baseline capillary density (PDR+: 45±7; PDR-: 46±9; controls: 48±10n/mm²; p-for-trend=0.05, Supplementary Figure 1A ) and during peak reactive hyperemia (PDR+: 62±12; PDR-: 65±16; controls: 67±17n/mm²; p-for-trend=0.06; Supplementary Figure 1B ) in PDR+ patients, whereas none of the between-group differences were significant. In all subjects with versus without cerebral microbleeds, irrespective of group allocation, capillary recruitment was lower (with: 29±15%, density at baseline 46±7 to 60±13n/mm² during peak reactive hyperemia; without: 40±16%, density at baseline 47±9 to 65±15n/mm² during peak reactive hyperemia; p=0.04; Figure 1C-D) . This difference was most notable in PDR+ patients (with cerebral microbleeds: 28±14%; without cerebral microbleeds: 41±17%; p=0.03; after adjustment for A1C, diabetes duration and ACR p=0.02).
Conclusions
In this study the relationship between cerebral small vessel disease and peripheral microvascular function in type 1 diabetes patients with and without proliferative retinopathy and healthy controls was investigated. Our results show that cerebral microbleeds, in contrast to ischemic small vessel disease, are more prevalent in PDR+ patients relative to the other groups. The prevalence of microbleeds in the other groups was low and most likely resembles previously described incidental findings (14) . Furthermore, capillary recruitment in skin was significantly impaired in participants with cerebral microbleeds, most notable in PDR+ patients.
Our finding that cerebral microbleeds prevalence is related to retinal microvascular abnormities has also been observed in type 2 diabetes patients (15) . We did not observe this relationship for ischemic small vessel disease. This may be due to etiological differences between these markers. Cerebral microbleeds are a marker of vessel wall leakage (9) , whereas white matter hyperintensities and lacunes represent ischemic tissue damage. Thus, microbleeds may more closely resemble cerebral microangiopathy and be comparable to microangiopathy measured at the retina and in skin, than the other markers. More research in larger samples is needed to confirm and expand these findings.
The associations between cerebral microbleeds and peripheral microvascular function in skin has not been reported before and supports the hypothesis that cerebral microbleeds are part of a generalized microvascular disorder, not limited to peripheral organs, such as the eyes and renal system.
Limitations of this study are differences in age and hypertension rates between the groups, for which all analyses were corrected. Additionally correcting for diabetes duration, A1C and ACR did not alter the results. .05); ‡ Diabetes early onset was defined as an onset age below the age of 7 years; § Severe hypoglycemic events were self-reported and defined as those events for which the patient needs assistance from a third person to recuperate due to loss of consciousness or seriously deranged functioning, coma or seizure due to low glucose levels; || Hypertension was defined as a systolic blood pressure of 140 mmHg or above, a diastolic blood pressure of 90 mmHg or above or use of antihypertensive drugs; ¶ Microalbuminuria was defined as an albumin-to-creatinine ratio >2.5 for men and >3.5 for women; # Neuropathy was based on the results of the annual check-up patients receive, of which the results are incorporated into the medical records, or if not available self-reported; ** Updated A1C represents the mean A1C level for the group with a median period of 7.0 years Data are presented as means with standard deviation; PDR-: T1DM without proliferative retinopathy; PDR+: T1DM with confirmed proliferative retinopathy; ACR: albumin-to-creatinine ratio; * Diabetes early onset was defined as an onset age below the age of 7 years; † Severe hypoglycemic events were self-reported and defined as those events for which the patient needs assistance from a third person to recuperate due to loss of consciousness or seriously deranged functioning, coma or seizure due to low glucose levels; ‡ Hypertension was defined as a systolic blood pressure of 140 mmHg or above, a diastolic blood pressure of 90 mmHg or above or use of antihypertensive drugs; § Microalbuminuria was defined as an albumin-to-creatinine ratio >2.5 for men and >3.5 for women; || Neuropathy was based on the results of the annual check-up patients receive, of which the results are incorporated into the medical records, or if not available self-reported; ¶ Updated A1C represents the mean A1C level for the group with a median period of 7.0 years prior to assessment.
Figure 1
Graphical representation of mean with standard error of the mean of skin capillary measures in all groups. Panel A represents baseline capillary density and panel B peak reactive hyperemia in controls (white), patients without retinopathy (gray) and those patients with retinopathy (black). Figure  1C represents the changes between mean baseline capillary density (BCD) and mean peak reactive hyperemia (PRH) in all participants without (white circles) and with (black squares) cerebral microbleeds irrespective of groups allocation. In Figure 1D the mean difference in capillary recruitment between all participants with (vertical stripes) and without (horizontal stripes) cerebral microbleeds is shown. Capillary recruitment was calculated as the relative increase in capillary density from baseline to peak reactive hyperemia. 
